Genetic alterations in chromosome 10q24.3 and glutathione S-transferase omega 2 gene polymorphism in ovarian cancer

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 107-114

  Pongstaporn, W ^a   Rochanawutanon, M ^a   Wilailak, S ^a   Linasamita, V ^a   Weerakiat, S ^a   Petmitr, Songsak ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Arbitrarily primed PCR; Chromosome 10q24.3; Gene polymorphism; Glutathione S transferase Omega 2; Ovarian cancer

Indexed keywords

GLUTATHIONE S TRANSFERASE OMEGA 2; GLUTATHIONE TRANSFERASE; PRIMER DNA; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 10Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; DNA POLYMORPHISM; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; OVARY CANCER; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 10; COMPUTATIONAL BIOLOGY; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MUTATION; ODDS RATIO; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 33646120798     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Stewart B.W., Kleihves P.: World Cancer Report. International Agency for Research on Cancer. Lyon, IARC press, 12-19, 2003.
2. Woodward P.J., Hosseinzadeh K., Saenger J.S.: Radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics 24:225-246, 2004.
3. Pataradool K., Kosiyatrakul T.: Ovary. In: Sriplung H., Sontipong S., Martin N., Wiangnon S., Vootiprux V., eds. Cancer in Thailand vol. III, 1995-1997. National Cancer Institute Thailand, 2003, 51-52.
4. Ozols R.F.: Progress in ovarian cancer an overview and perspective. Eur. J. Cancer supplement 1:43-55, 2003.
5. Navarro J.M., Jorcano J.L.: The use of arbitrarily primed polymerase chain reaction in cancer research. Electrophoresis 20: 283-290, 1999.
6. Malkhosyan S., Yasuda J., Soto J.L., Sekiya T., Yokota J., Perucho M.: Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc.Natl.Acad. Sci. USA. 95:10170-10175, 1998.
7. Peinado M.A., Malkhosyan S., Velazquez A., Perucho M.: Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 89:10065-10069, 1992.
8. Achille A., Biasi M.O., Zamboni G., et al.: Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res. 56:3808-3813, 1996.
9. de Juan C., Iniesta P., Vega F.J., et al.: Prognostic value of genomic damage in non-small cell lung cancer. Br. J. Cancer 77:1971-1977, 1998.
10. Kawakami K., Yasuda J., Shiraishi M., et al.: Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers. Biochem. Biophys. Res. Commun. 251:154-157, 1998.
11. Ong T.-M., Qian H.-W., Wu Z.L., Whong W.-Z.: Detection of genomic instability in lung cancer tissues by random amplified polymorphic DNA analysis. Carcinogenesis 19:233-235, 1998.
12. Yamada T., Kohno T., Navarro J.M., et al.: Frequent chromosome 8q gains in human small cell lung cancer detected by arbitrarily primed-PCR genome fingerprinting. Cancer Genet. Cytogenet. 120:11-17, 2000.
13. Yoshiki S., Bruner J.M., Levin V.A., Kyritsis A.P.: Identification of allelic loss on chromosome arm 6p in human astrocytomas by arbitrarily primed polymerase chain reaction. Gene Chromosome Cancer 22:165-170, 1998.
14. Takashi M., Jikko A., Hiranuma H., Fuchihata H.: Analysis of genomic instability in squamous cell carcinoma of the head and neck using the random amplified polymorphic DNA method. Cancer Lett. 138:183-188, 1999.
15. Piao Z., Lee K.S., Kim H., Perucho M., Malkhosyan S.: Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis. Gene Chromosome Cancer 30:13-122, 2001.
16. Singh K.P., Deodutta R.: Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting. Gene 269:33-43, 2001.
17. Miller S.A., Dykes D.D., Polsky H.F.: Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215, 1988.
18. Williams J.G., Kubelik A.R., Livak K.J., Rafalski J.A., Tingey S.V.: DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 18:6531-6535, 1990.
19. Livak K.J., Schmiltgen T.D.: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta Delta (Ct) Method. Methods 25:407-408, 2001.
20. Hayashi K.: PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1:34-38, 1991.
21. Enomoto T., Weghost C.M., Inoue M., Tanizawa O., Rice J.M.: K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am.J.Pathol. 139:777-785, 1991.
22. Fajac A., Benard J., Lhomme C., et al.: B-2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int. J. Cancer 64:146-151, 1995.
23. Ross J.S., Yang F., Kallakury B.V., et al.: HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary. Am.J.Clin.Pathol. 111:311-316, 1999.
24. McManus D.T., Yap E.P., Maxwell P., et al.: P53 expression, mutation and allelic deletion in ovarian cancer. J.Pathol. 174:159-168, 1994.
25. Guengerich F.P., Thier R., Persmark M., et al.: Conjugation of carcinogens by theta class glutathione S-transferases: mechanisms and relevance to variations in human risk. Phamacogenetics 5 suppl.:103-107, 1995.
26. To-Figueras J., Gene M., Gomez-Catalan J., et al.: Polymorphism of glutathione-S- transferase M3: interaction with glutathione-S-transferase M1 and lung cancer susceptibility. Biomarkers 5:73-80, 2000.
27. Townsend D.M., Tew K.D.: The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369-75, 2003.
28. Townsend D.M., Tew K.D.: Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am.J.Pharmacogenomics 3:157-172, 2003.
29. Strange R.C., Fryer A.A.: The glutathione-S-transferases: influence of polymorphism on cancer susceptibility: Metabolic Polymorphisms and Susceptibility to Cancer, IARC Scientific Publications no. 148, Lyon, IARC, 1999, 231-249.
30. Zheng T., Holford T.R., Zahm S.H., et al.: Glutathione-S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk Br. J. Cancer 88:58-62, 2003.
31. Smith R.A., Curran J.E., Weinstein S.R., Griffiths L.R.: Investigation of glutathione-S-transferase zeta and the development of sporadic breast cancer. Breast Cancer Res. 3:409-411, 2001.
32. Ketterer B., Harris J.M., Talaska G., et al.: The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Enviro. Health Perspect. 98:87-94, 1992.
33. Lewis S.J., Cherry N.M., Mc Niven R., Barber P.V., Povey A.C.: GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 180:165-171, 2002.
34. Miller D.P., Liu G., De Vivo I., et al.: Combinations of the variant genotypes of GSTP1, GSTM1 and p53 are associated with an increased lung cancer risk. Cancer Res. 62:2819-2823, 2002.
35. Stiicker I., Hirvonen A., de Waziers I., et al.: Genetic polymorphisms of glutathione-S-transferase as modulators of lung cancer susceptibility. Carcinogenesis 23:1475-1481, 2002.
36. Loktionov A., Watson M.K., Gunter M., et al.: Glutatione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 22:1053-1060, 2001.
37. Spurdle A.B., Webb P.M., Purdle D.M., et al.: Polymorphisms at the glutathione-S-Transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 22:67-72, 2001.
38. Howells R.E.J., Holland T., Dhar K.K., et al. Glutathione-S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival. Int.J.Gynecol. Cancer 11:107-112, 2001.
39. Lallas T.A., McClain S.K., Shabin M.S., Buller R.E.: The glutathione-S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 9:587-590, 2000.
40. Whitbread A.K., Tetlow N., Eyre H.J., Sutherland G.R., Board P.G.: Characterization of the human Omega class glutathione transferase genes and associated polymorphism. Pharmacogenetics 13:131-144, 2003.
41. Board P.G., Coggan M., Chelvanayagam G., et al.: Identification, characterization, and crystal structure of the Omega class glutathione S-transferases. J.Biol.Chem. 275:24798-24806, 2000.